基于效用的个体化最优剂量选择:机器学习方法的应用
本文提出用随机森林和高斯过程模型,结合剂量与生物标志物建模疗效与毒性,并用Copula建模二者联合分布,以临床医生赋予的数值效用最大化后验均值来选择每位患者的最优剂量。模拟研究显示高斯过程模型表现优于随机森林,建模时强制单调性有小幅获益,是否建模疗效与毒性相关性影响甚微,并用肝癌立体定向体部放疗患者研究进行示例。
要点
- 以临床医生赋予的双变量结局数值效用最大化为目标选择个体最优剂量
- 高斯过程模型在模拟研究中表现优于随机森林模型
- 建模时强制剂量-疗效与剂量-毒性单调关系有小幅获益
核心结论
- 所提出的基于效用的机器学习方法可用于个体化最优剂量选择,高斯过程模型表现优于随机森林,强制单调性有小幅获益,是否建模疗效与毒性相关性影响甚微。
研究设计与样本
- 方法学研究,考虑一个二分类疗效结局和一个二分类毒性结局,使用随机森林和高斯过程等灵活机器学习方法建模,并用Copula建模两个结局的联合分布。
- 通过模拟研究比较不同估计最优剂量规则下的期望效用表现,并以接受立体定向体部放疗的肝癌患者研究进行示例。
主要发现
- 高斯过程模型在模拟研究中表现优于随机森林模型。
- 建模时强制单调性提供了小幅获益。
- 是否以及如何建模疗效与毒性之间的相关性对性能影响很小。
关键数值与推荐
- 数值效用由临床医生针对每个潜在的双变量结局赋予。
- 对每位患者,选择使效用函数后验均值最大化的剂量作为最优剂量。
- 估计约束为剂量-疗效和剂量-毒性关系非递减。
- 还提出了加入基于毒性的额外约束以及考虑效用函数估计不确定性的替代最优剂量选择方法。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal in personalized medicine is to individualize treatment using patient characteristics and improve health outcomes. Selection of optimal dose must balance the effect of dose on both treatment efficacy and toxicity outcomes. We consider a setting with one binary efficacy and one binary toxicity outcome. The goal is to find the optimal dose for each patient using clinical features and biomarkers from available dataset. We propose to use flexible machine learning methods such as random forest and Gaussian process models to build models for efficacy and toxicity depending on dose and biomarkers. A copula is used to model the joint distribution of the two outcomes and the estimates are constrained to have non-decreasing dose-efficacy and dose-toxicity relationships. Numerical utilities are elicited from clinicians for each potential bivariate outcome. For each patient, the optimal dose is chosen to maximize the posterior mean of the utility function. We also propose alternative approaches to optimal dose selection by adding additional toxicity based constraints and an approach taking into account the uncertainty in the estimation of the utility function. The proposed methods are evaluated in a simulation study to compare expected utility outcomes under various estimated optimal dose rules. Gaussian process models tended to have better performance than random forest. Enforcing monotonicity during modeling provided small benefits. Whether and how, correlation between efficacy and toxicity, was modeled, had little effect on performance. The proposed methods are illustrated with a study of patients with liver cancer treated with stereotactic body radiation therapy.
引用
- Li P, Taylor JMG, Boonstra PS, et al. Utility based approach in individualized optimal dose selection using machine learning methods. Stat Med. 2022. PMID: 35343595. doi:10.1002/sim.9396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。